Augmenting Urinary Reflex Activity: Study 3

Therapy Optimisation Study of Adaptive Pudendal Neuromodulation in Women With Urinary Incontinence Implanted With the Amber UI System.

AURA-3 study (Augmenting Urinary Reflex Activity Study 3) is a single arm, short-duration (8 month) cohort follow up study of preceding interventional medical device study, AURA-2.

Inclusion Criteria:

• Participant has exited the AURA-2 clinical investigation.
• Participant has an implanted Amber UI system.
• Consents to participation.

Exclusion Criteria:

• Participant has withdrawn from AURA-2 clinical investigation.
• Participant is pregnant.
• A past or current condition that in the opinion of the PI contraindicates enrolment (PI discretion).